WebNovaBay Pharmaceuticals, Inc About Technology Brands Investors News Contact TOP About Management Team Board of Directors Contact Us Technology Pure HOCI Brands … SEC Filings. For filings please visit: United States: SEC Filings Canada: SEDAR Filings NovaBay is proud to offer a specialized portfolio of innovative, non-antibiotic, anti … Telephone, Fax, and Website. Toll Free in the US +1 800 962 4284 Telephone +1 … AVENOVA® EFFECTIVE RELIEF – Previously available by prescription only, … Technology. We’ve developed our pure hypochlorous acid (HOCI) and Aganocide … News. Explore the latest NovaBay news and information including all current and … NovaBay’s pure HOCl products have been cleared by the Food & Drug … Aganocides® Our first-in-class Aganocide compounds, led by auriclosene (NVC … WebNovaBay Pharmaceuticals Inc（NBY）的毛利率 ％为48.17％ (2024年12月 最新), 点击查看毛利率 ％(Gross Margin %)的详细解释与计算方法，以及NovaBay Pharmaceuticals Inc与其相关公司的历史数据和行业比较等信息。 NovaBay Pharmaceuticals Inc（NBY）的毛利率 ％为48.17％ (2024年12月 最新), 点击查看毛利率 ％(Gross Margin %)的详细解释与计算 …
NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by …
WebApr 14, 2024 · About NBY. NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. … Web1 day ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or … ciaz with spoiler
NovaBay Pharmaceuticals, Inc. (NBY) - Stock Analysis
WebNov 5, 2024 · NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2024 and provides a business update. Financial results for 2024 include DERMAdoctor ®, which NovaBay acquired on November 5, 2024. WebNovaBay Pharmaceuticals Inc（NBY）的净利率 ％为-225.25％ (2024年12月 最新), 点击查看净利率 ％(Net Margin %)的详细解释与计算方法，以及NovaBay Pharmaceuticals Inc与其相关公司的历史数据和行业比较等信息。 NovaBay Pharmaceuticals Inc（NBY）的净利率 ％为-225.25％ (2024年12月 最新), 点击查看净利率 ％(Net Margin %)的详细解释与计算方法， … WebApr 13, 2024 · Stock analysts at StockNews.com assumed coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Rating) in a research report issued on Tuesday. The … cib230 fund fact